Impact of Hypertension and Hyperlipidemia Screening with Intervention During the Utilization of Antihypertensive and Antihyperlipidemic Drugs

Madheswaran M, Parimalakrishnan S, Manivannan R


The aim of the present study is to estimate the impact of intervention provided on screening programme to the participants and physicians and also proposed to study the factors influencing the physicians during prescribing antihypertensive and/ or antilipidemic agents. The study design was a cohort intervention study done at community pharmacies at Tamil Nadu, India. This was carried out for two years and data were collected from the patient record and interview. A screening prgoramme was arranged to measure blood pressure and total cholesterol levels. The primary outcome of measures was the percentage of patients prescribed antihypertensive and/ or antihyperlipidemic agents for 6 months before and after the intervention. Data were collected from 946 (75.68%) of patients visited the identified community pharmacies. 90.6%  and 9.4%of patients were allotted to the control and intervention groups to initiate antihypertensive and/ or antihyperlipidemic agents. After the intervention, the prevalence of antihypertensive agents prescribed was observed high among the intervention group when compared with the control group as the prevalence of antihyperlipidemic prescription. The similar results for the incidence were also observed for the antihypertensive agents and antihyperlipidemic agent prescription, during the study period after the intervention. This present study showed that the intervention was effective for improving the prescription containing antihypertensive and antihyperlipidemic agents as a primary outcome among patients with high blood pressure and lipid levels.

Full Text:



Kevin Mc Namara, Hamzah Alzubaidi and John Keith Jackson. Cardiovascular disease as a leading cause of death: how are pharmacists getting involved?. Integ Pharm Res Prac. 2019; 8: 1-11.

Thomas A Gaziano, Asaf Bitton, Shuchi Anand, Shafika Abrahams Gessel and Adrianna Murphy. Growing epidemic of coronary heart disease in low- and middle income countries. Curr Probl Cardiol. 2010; 35(2): 72–115.

Institute of medicine committee on preventing the global epidemic of cardiovascular disease: meeting the challenges in developing countries; Fuster V and Kelly BB, Editors. Promoting cardiovascular health in the developing world: a critical challenge to achieve global health. Washington (DC): National Academies Press (US); 2010. 2, Epidemiology of cardiovascular disease. Available from:

Francesco Paolo Cappuccio and Michelle Avril Miller. Cardiovascular disease and hypertension in sub-Saharan Africa: burden, risk and interventions. Intern Emerg Med, 2016; 11: 299–305.

Barnes VA and Orme-Johnson DW. Prevention and treatment of cardiovascular disease in adolescents and adults through the transcendental meditation® program: A Research Review Update. Curr Hypertens Rev. 2012; 8(3):227–242.

National Clinical Guideline Centre (UK). Hypertension: the clinical management of primary hypertension in adults: update of clinical guidelines 18 and 34 [Internet]. London: Royal College of Physicians (UK); 2011 Aug. (NICE clinical guidelines, No. 127.) 7, Diagnosis of hypertension. Available from:

Santschi Valérie, Chiolero Arnaud, Burnand Bernard, Colosimo April and Paradis Gilles. Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials. Arch Intern Med, 2011; 171: 1441-1453.

Jimmy B and Jose J. Patient medication adherence: measures in daily practice. Oman Med J. 2011 Apr; 26(3): 155–159.

Brown MT and Bussell JK. Medication adherence: WHO cares?. Mayo Clin Proc. 2011; 86(4): 304–314.

Jainaf Nachiya RAM, Parimalakrishnan S and Ramakrishna Rao M. Study on drug utilization pattern of antihypertensive medications on out-patients and inpatients in a tertiary care teaching hospital: A cross sectional Study. Afr J Pharm Pharmacol, 2011; 9: 383-396.

Atthobari J. Drug use in population screening. Pharmacoepidemiological and pharmacoeconomical aspects. Ph.D Thesis, Faculty of Mathematics, University of Groningen, Palembang, Indonesia. (2006).

Cologne, Germany: Institute for quality and efficiency in health care; 2006 - high cholesterol: Overview. 2013 Aug 14. Available from:

Marfella, Raffaele Siniscalchi, Mario Esposito, Katherine Sellitto, Ausilia de Fanis, Umberto Romano, et al. Effects of stress hyperglycemia on acute myocardial infarction. Diab Care, 2003; 26(11): 3129 – 3135.

Joshi SR, Anjana RM, Deepa M, Pradeepa R, Bhansali A, et al. (2014) Prevalence of Dyslipidemia in Urban and Rural India: The ICMR–INDIAB Study. PLoS ONE, 2014; 9(5): e96808.


  • There are currently no refbacks.